CEDIA dau Benzodiazepine screening assay: A reformulation

Journal of Analytical Toxicology

Volumn 22, Issue 4, 1998, Pages 270-273

  Meatherall, Robert C ^a   Fraser, Albert D ^b  

^a ST BONIFACE GENERAL HOSPITAL   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BETA GLUCURONIDASE; DRUG METABOLITE; LORAZEPAM; LORAZEPAM GLUCURONIDE; NITRAZEPAM; NOVOLORAZEPAM; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG CROSS REACTIVITY; DRUG HYDROLYSIS; DRUG SCREENING; DRUG URINE LEVEL; ESCHERICHIA COLI; FEMALE; HELIX POMATIA; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION;

EID: 0031830276     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/22.4.270     Document Type: Article

References (12)

1. R. Meatherall. Benzodiazepine screening using EMIT II® and TDx®: urine hydrolysis pretreatment required. J. Anal. Toxicol. 18: 385-390 (1994).
2. A.D. Fraser and R. Meatherall. Comparative evaluation of five immunoassays for the analysis of alprazolam and triazolam metabolites in urine: effect of lowering the screening and GC-MS cut-off values. J. Anal. Toxicol. 20: 217-223 (1996).
3. A.B. Boussairi, J.P. Dupeyron, B. Hernandez, D. Delaitre, L. Beaugnet, P. Espinoza, and O. Diamant-Berger. Urine benzodiazepines screening of involuntarily drugged and robbed or raped patients. Clin. Toxicol. 34: 721-724 (1996).
4. P. Simonsson, A. Linden, and S. Lindberg. Effect of β-glucuronidase on urinary benzodiazepine concentrations determined by fluorescence polarization immunoassay. Clin. Chem. 41: 920-923 (1995).
5. P.T. Mearrick and J.S. Chahl. Screening for benzodiazepines in urine after hydrolysis of glucuronide conjugates. Clin. Chem. 31: 152 (1985).
6. O. Beck, P. Lafolie, P. Hjemdahl, S. Borg, G. Odelius, and P. Wirbing. Detection of benzodiazepine intake in therapeutic doses by immunoanalysis of urine: two techniques evaluated and modified for improved performance. Clin. Chem. 38: 271-275 (1992).
7. D.R. Henderson, S.B. Friedman, J.D. Harris, W.B. Manning, and M.A. Zoccoli. CEDIA, a new homogeneous immunoassay system. Clin. Chem. 32: 1637-1641 (1986).
8. R. Meatherall. GC-MS confirmation of urinary benzodiazepine metabolites. J. Anal. Toxicol. 18: 369-391 (1994).
9. Beckman Synchron CX® Delta Systems creatinine assay, Kit #443340, Beckman Instruments Inc., Mississauga, ON, Canada.
10. R. Meatherall. Optimal enzymatic hydrolysis of urinary benzodiazepine conjugates. J. Anal. Toxicol. 18: 382-384 (1994).
11. C.L. O'Neal and A. Poklis. Evaluation of (R,S) oxazepam and lorazepam β-glucuronide primary reference materials. Presented at the Society of Forensic Toxicologists annual meeting, Baltimore, MD, October 1995.
12. C.L. O'Neal and A. Poklis. Validation of benzodiazepine beta glucuronide primary reference materials for hydrolysis and quality assurance controls. Forensic Sci. Int. 79: 69-81 (1996).